On February 18, 2020 Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, reported that its President and Chief Executive Officer, Peter L. Hoang, will present at two upcoming investor conferences (Press release, Marker Therapeutics, FEB 18, 2020, View Source [SID1234554475]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Details

Cowen 40th Annual Health Care Conference
Date: Wednesday, March 4, 2020
Time: 8:40 a.m. ET
Location: Boston, MA

Oppenheimer 30th Annual Healthcare Conference
Date: Wednesday, March 18, 2020
Time: 1:35 p.m. ET
Location: New York, NY

Live webcasts of the presentations will be accessible from the investors section of the company’s website at markertherapeutics.com and will be available for replay following the event.